ArticleCureus2026
Perioperative Systemic Analgesia in Patients With Inflammatory Skin Disease: A Matched Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic inflammatory dermatoses are associated with altered nociception and increased opioid use in nonsurgical settings, but perioperative analgesic prescribing in this population has not been well characterized. We compared perioperative analgesic use, recorded postoperative pain, and surgical outcomes between surgical patients with and without inflammatory skin disease.
methodsWe conducted a retrospective propensity score-matched cohort study using the TriNetX federated electronic health record network. Patients with inflammatory dermatoses undergoing surgery were matched 1:1 to controls without inflammatory skin disease. A secondary matched cohort of patients with postprocedural pain was analyzed to evaluate analgesic prescribing following documented postoperative pain. Outcomes included opioid and non-opioid analgesic use, postoperative pain, complications, and postoperative nausea and vomiting (PONV).
resultsAfter matching, the surgical cohort included 38,569 patients per group and the postprocedural-pain cohort included 149,002 patients per group. Thirty-day opioid use, the primary outcome, was lower in the inflammatory cohort than in controls (3.2% vs 7.0%; risk difference (RD), -3.8 percentage points; 95% confidence interval (CI), -4.2 to -3.4; risk ratio (RR), 0.46; 95% CI, 0.42-0.50), with lower opioid and non-opioid analgesic use persisting across the evaluated follow-up periods. Despite reduced analgesic use, recorded postoperative pain was similar at 30 days and higher during longer follow-up. PONV occurred more frequently in patients with inflammatory dermatoses, while most other postoperative complications were comparable between groups.
conclusionsPatients with inflammatory dermatoses received less perioperative systemic analgesia despite no reduction in recorded postoperative pain. Because lower prescribing alone cannot establish undertreatment without validated pain severity or patient-reported outcomes, we interpret these associations as hypothesis-generating; they identify a potential difference in perioperative pain management and highlight the need for prospective studies to better define analgesic needs in surgical patients with inflammatory skin disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.